Researchers continue exploring how hemp-derived cannabinoids may interact with cellular stress and inflammatory pathways involved in disease progression. In the study “Cannabigerol induces endoplasmic reticulum stress-mediated apoptosis and ferroptosis via the IRE1α-XBP1 axis in human pancreatic cancer cells,” scientists investigated how cannabigerol (CBG) affected human pancreatic cancer cells in laboratory models. The findings showed that […]
Tag: CBG
Cannabigerol (CBG) Derivatives Show Strong Antibacterial Activity Against Gram-Positive Bacteria (pub. March 2026)
As antibiotic resistance continues to rise, researchers are exploring how modifying natural compounds like cannabigerol (CBG) can enhance their antibacterial effects. This study examined the structure–activity relationships (SAR) of CBG and its precursor cannabigerolic acid (CBGA) to understand how changes in their chemical structure impact their ability to fight Gram-positive bacteria. Scientists tested a range […]
CBG and CBD May Interact Differently Within the Body’s Detoxification Pathways (Pub. May 2026)
As research into hemp-derived cannabinoids continues to expand, scientists are learning that cannabinoids like CBD and CBG may affect the body in very different ways. In the study “Cannabigerol and cannabidiol differ in their ability to affect the AhR/CYP1A pathway in vitro,” researchers explored how these two cannabinoids interact with biological pathways connected to detoxification […]